• 1
    Edwards CJ, Arden NK, Fisher D, Saperia JC, Reading I, van Staa TP, et al. The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database. Rheumatology (Oxford) 2005; 44: 13948.
  • 2
    Rahman MM, Leong KP, Edwards CJ, Chng HH. Five-and-a-half year study of 107 patients with septic arthritis in a general hospital in Singapore. APLAR Journal of Rheumatology 2003; 6: 105.
  • 3
    Cooper C, Cawley MI. Bacterial arthritis in an English health district: a 10 year review. Ann Rheum Dis 1986; 45: 45863.
  • 4
    Kaandorp CJ, van Schaardenburg D, Krijnen P, Habbema JD, van de Laar MA. Risk factors for septic arthritis in patients with joint disease: a prospective study. Arthritis Rheum 1995; 38: 181925.
  • 5
    Gupta MN, Sturrock RD, Field M. A prospective 2-year study of 75 patients with adult-onset septic arthritis. Rheumatology (Oxford) 2001; 40: 2430.
  • 6
    Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF-alpha therapy. J Exp Med 2004; 200: 27785.
  • 7
    The general practice research database: information for researchers. London: Office for National Statistics; 1996.
  • 8
    Hall G. Pharmacoepidemiology using a UK database of primary care records. Pharmacoepidemiol Drug Saf 1992; 1: 337.
  • 9
    Hollowell J. General practice research database (GPRD): scope and quality of data. London: Office of Population Censuses and Statistics; 1994.
  • 10
    Lis Y, Mann RD. The VAMP research multi-purpose database in the UK. J Clin Epidemiol 1995; 48: 43143.
  • 11
    Mann RD, Hall G, Chukwujindu J. Research implications of computerised primary care. Post Marketing Surveillance 1992; 5: 25969.
  • 12
    Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 2000; 39: 13839.
  • 13
    Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997; 350: 10979.
  • 14
    Van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HG. The use of a large pharmacoepidemiological database to exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf 2000; 9: 35966.
  • 15
    Lewis JD, Brensinger C, Bilker WB, Strom BL. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf 2002; 11: 2118.
  • 16
    Ryan MJ, Kavanagh R, Wall PG, Hazleman BL. Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period. Br J Rheumatol 1997; 36: 3703.
  • 17
    Kaandorp CJ, Krijnen P, Moens HJ, Habbema JD, van Schaardenburg D. The outcome of bacterial arthritis: a prospective community-based study. Arthritis Rheum 1997; 40: 88492.
  • 18
    Kaandorp CJ, Dinant HJ, van de Laar MA, Moens HJ, Prins AP, Dijkmans BA. Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis 1997; 5: 4705.
  • 19
    Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P. Cyclophosphamide for treating rheumatoid arthritis. Cochrane Database Syst Rev 2000; 4: CD001157.
  • 20
    Jansen TL, van Heereveld HA, Laan RF, Barrera P, van de Putte LB. Septic arthritis with Listeria monocytogenes during low-dose methotrexate. J Intern Med 1998; 244: 8790.
  • 21
    Jobanputra P, Maggs F, Homer D, Bevan J. Monitoring and assessing the safety of disease-modifying antirheumatic drugs: a West Midlands experience. Drug Saf 2002; 25: 1099105.
  • 22
    Cassuto-Viguier E, Mondain JR, van Elslande EL, Bendini JC, Gaid H, Franco M, et al. Fatal outcome of Aspergillus fumigatus arthritis in a renal transplant recipient. Transplant Proc 1995; 2: 2461.
  • 23
    Amital H, Aamar S, Rubinow A. Bilateral septic arthritis of the hip: does etanercept play a role? A case report. J Bone Joint Surg Am 2003; 85: 22056.
  • 24
    Baghai M, Osmon DR, Wolk DM, Wold LE, Haidukewych GJ, Matteson EL. Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept. Mayo Clin Proc 2001; 76: 6536.
  • 25
    Bassetti S, Wasmer S, Hasler P, Vogt T, Nogarth D, Frei R, et al. Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment. J Rheumatol 2005; 32: 21259.
  • 26
    Elwood RL, Pelszynski MM, Corman LI. Multifocal septic arthritis and osteomyelitis caused by group A Streptococcus in a patient receiving immunomodulating therapy with etanercept. Pediatr Infect Dis J 2003; 22: 2868.
  • 27
    Katsarolis I, Tsiodras S, Panagopoulos P, Giannitsioti E, Skarantavos G, Ioannidis T, et al. Septic arthritis due to Salmonella enteritidis associated with infliximab use. Scand J Infect Dis 2005; 37: 3045.
  • 28
    Kaur PP, Derk CT, Chatterji M, Dehoratius RJ. Septic arthritis caused by Actinobacillus ureae in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha therapy. J Rheumatol 2004; 31: 16635.
  • 29
    Nadarajah K, Pritchard C. Listeria monocytogenes septic arthritis in a patient treated with etanercept for rheumatoid arthritis. J Clin Rheumatol 2005; 11: 1202.
  • 30
    Olivieri I, Padula A, Armignacco L, Sabatella V, Mancino M. Septic arthritis caused by Moraxella catarrhalis associated with infliximab treatment in a patient with undifferentiated spondarthritis. Ann Rheum Dis 2004; 63: 1056.
  • 31
    Rachapalli S, O'Daunt S. Septic arthritis due to Listeria monocytogenes in a patient receiving etanercept [letter]. Arthritis Rheum 2005; 52: 987.
  • 32
    Schett G, Herak P, Graninger W, Smolen JS, Aringer M. Listeria-associated arthritis in a patient undergoing etanercept therapy: case report and review of the literature. J Clin Microbiol 2005; 43: 253741.